» Authors » Vasilis Babaliaros

Vasilis Babaliaros

Explore the profile of Vasilis Babaliaros including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 167
Citations 8601
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hahn R, Pibarot P, Abbas A, Makkar R, Thourani V, Genereux P, et al.
JACC Cardiovasc Interv . 2025 Feb; 18(4):506-517. PMID: 40010919
Background: Short-term clinical outcomes after transcatheter aortic valve replacement (TAVR) are similar in individuals with small or large annuli. The longer term impact of prosthesis-patient mismatch (PPM) and mean gradient...
2.
Samim D, Sorajja P, Lanz J, Stolz L, Angellotti D, Hausleiter J, et al.
JACC Cardiovasc Interv . 2025 Feb; 18(3):311-321. PMID: 39939035
Background: Management of recurrent mitral regurgitation (MR) or relevant iatrogenic mitral valve (MV) stenosis after mitral transcatheter edge-to-edge repair (M-TEER) emerges as an increasingly relevant clinical issue. Surgery after M-TEER...
3.
Thourani V, Leon M, Makkar R, Ascione G, Szeto W, Madhavan M, et al.
Ann Thorac Surg . 2024 Dec; 119(3):555-566. PMID: 39694217
Background: Surgery remains an important treatment for low-risk patients with severe symptomatic aortic stenosis (AS). This study evaluated 5-year outcomes in low-risk patients undergoing isolated surgical aortic valve replacement (SAVR)...
4.
Genereux P, Schwartz A, Oldemeyer J, Pibarot P, Cohen D, Blanke P, et al.
N Engl J Med . 2024 Oct; 392(3):217-227. PMID: 39466903
Background: For patients with asymptomatic severe aortic stenosis and preserved left ventricular ejection fraction, current guidelines recommend routine clinical surveillance every 6 to 12 months. Data from randomized trials examining...
5.
Dimas V, Babaliaros V, Kim D, Lim D, Morgan G, Jones T, et al.
JACC Cardiovasc Interv . 2024 Oct; 17(19):2287-2297. PMID: 39415386
Background: A dilated native right ventricular outflow tract (RVOT) presents unique challenges for transcatheter management using balloon-expandable valves. The Alterra Adaptive Prestent was designed to expand transcatheter therapy to treat...
6.
Sadri V, Midha P, Madukauwa-David I, Kamioka N, Trusty P, Nair P, et al.
Cardiovasc Eng Technol . 2024 Sep; 15(6):749-759. PMID: 39285066
Purpose: Neo-sinus flow stasis has ben correlated with transcatheter heart valve (THV) thrombosis severity and occurrence. Standard benchtop flow field quantification techniques require optical access or modified prosthesis models that...
7.
Shekiladze N, Murphy A, Babaliaros V, Ueyama H, Greenbaum A, Gleason P, et al.
J Soc Cardiovasc Angiogr Interv . 2024 Aug; 3(5):101352. PMID: 39132463
Coronary artery obstruction is an uncommon yet devastating complication of transcatheter aortic valve replacement (TAVR) and may necessitate leaflet modification. A 38-year-old man presented to our center with quadricuspid aortic...
8.
Lisko J, Shekiladze N, Chamoun J, Sheikh N, Rainer K, Wei J, et al.
J Soc Cardiovasc Angiogr Interv . 2024 Aug; 3(1):101184. PMID: 39131978
Background: Radiation exposure during invasive cardiovascular procedures remains an important health care issue. Lead aprons and shields (LAS) are used to decrease radiation exposure but leave large portions of the...
9.
Conradi L, Ludwig S, Sorajja P, Duncan A, Bethea B, Dahle G, et al.
EuroIntervention . 2024 Jul; 20(14):e887-e897. PMID: 39007829
Background: Transcatheter mitral valve replacement (TMVR) is a therapeutic option for patients with severe mitral regurgitation (MR) who are ineligible for conventional surgery. There are limited data on the outcomes...
10.
Duncan A, Sorajja P, Dahle G, Denti P, Badhwar V, Conradi L, et al.
JACC Cardiovasc Interv . 2024 Jul; 17(13):1625-1627. PMID: 38986665
No abstract available.